Trials / Completed
CompletedNCT04924153
A Natural History Study of Participants With Potassium Sodium-Activated Channel Subfamily T Member 1 (KCNT1)-Related Epilepsy
A Non-Drug, Longitudinal, Prospective Natural History Study of Individuals With KCNT1-Related Epilepsy (K1Te)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 0 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to characterize seizures in participants with KCNT1-related epilepsy. The secondary objectives are to characterize head growth, symptom severity, neurocognitive and social functions, adaptive behavior, sleep, quality of life, caregiver burden, and mood in participants with KCNT1-related epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2021-08-17
- Primary completion
- 2023-08-29
- Completion
- 2023-08-29
- First posted
- 2021-06-11
- Last updated
- 2024-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04924153. Inclusion in this directory is not an endorsement.